S&P Futures
4,381.50 -93.25 (-2.08%) Dow Futures
34,105.00 -511.00 (-1.48%) Nasdaq Futures
14,411.00 -430.00 (-2.90%) Russell 2000 Futures
1,984.00 -37.20 (-1.84%) Crude Oil
84.83 -0.72 (-0.84%) Gold
1,836.10 -6.50 (-0.35%)
DURECT Corporation (DRRX)
After hours:
Chart Events
Performance Outlook
| Previous Close | 0.6798 |
| Open | 0.6682 |
| Bid | 0.6700 x 1100 |
| Ask | 0.6880 x 900 |
| Day's Range | 0.6500 - 0.7143 |
| 52 Week Range | 0.6500 - 2.9500 |
| Volume | |
| Avg. Volume | 745,251 |
| Market Cap | 150.131M |
| Beta (5Y Monthly) | 1.15 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.1140 |
| Earnings Date | Mar 02, 2022 - Mar 07, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 6.00 |
- Zacks
Here's Why Durect (DRRX) is Poised for a Turnaround After Losing 17.1% in 4 Weeks
Durect (DRRX) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
- PR Newswire
DURECT Corporation to Participate in H.C. Wainwright Bioconnect Conference
DURECT Corporation (Nasdaq: DRRX) today announced that Dr. James E. Brown, President and CEO, Michael H. Arenberg, Chief Financial Officer, and Dr. Norman Sussman, Chief Medical Officer will present at the H.C. Wainwright Bioconnect Conference which will be available on demand starting on January 10, 2022.
- PR Newswire
DURECT and Innocoll Announce a $136 Million U.S. Licensing Agreement for POSIMIR® (Bupivacaine Solution)
DURECT Corporation (Nasdaq: DRRX) today announced a licensing agreement granting Innocoll Biotherapeutics plc, a specialty pharmaceutical company and portfolio business of Gurnet Point Capital, exclusive development and commercialization rights to POSIMIR® (bupivacaine solution) for infiltration use, DURECT's FDA-approved non-opioid, sustained-release local analgesic for the treatment of post-surgical pain in adults following arthroscopic subacromial decompression surgery, in the United States.
